|
1
|
Nguyen TH, Liu X, Su ZZ, Hsu AC, Foster PS
and Yang M: Potential role of MicroRNAs in the regulation of
antiviral responses to influenza infection. Front Immunol.
9:15412018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei Y, Zhu M and Schober A: Macrophage
MicroRNAs as therapeutic targets for atherosclerosis, metabolic
syndrome, and cancer. Int J Mol Sci. 19:E17562018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan YC, Banerjee J, Choi SY and Sen CK:
miR-210: The master hypoxamir. Microcirculation. 19:215–223. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chan SY and Loscalzo J: MicroRNA-210: A
unique and pleiotropic hypoxamir. Cell Cycle. 9:1072–1083. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mutharasan RK, Nagpal V, Ichikawa Y and
Ardehali H: microRNA-210 is upregulated in hypoxic cardiomyocytes
through Akt- and p53-dependent pathways and exerts cytoprotective
effects. Am J Physiol Heart Circ Phyiol. 301:H1519–H1530. 2011.
View Article : Google Scholar
|
|
6
|
Zeng L, Liu J, Wang Y, Wang L, Weng S,
Tang Y, Zheng C, Cheng Q, Chen S and Yang GY: MicroRNA-210 as a
novel blood biomarker in acute cerebral ischemia. Front Biosci
(Elite Ed). 3:1265–1272. 2011.PubMed/NCBI
|
|
7
|
Dang K and Myers KAL: The role of
hypoxia-induced miR-210 in cancer progression. Int J Mol Sci.
16:6353–6372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang Q, Chen SS, Li J, Tao SS, Wang M,
Leng RX, Pan HF and Ye DQ: miR-210 expression in PBMCs from
patients with systemic lupus erythematosus and rheumatoid
arthritis. Ir J Med Sci. 187:243–249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan SL, Wong VW, Qin S and Chan HL:
Infection and cancer: The case of hepatitis B. J Clin Oncol.
34:83–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wen WH, Huang CW, Chie WC, Yeung CY, Zhao
LL, Lin WT, Wu JF, Ni YH, Hsu HY, Chang MH, et al: Quantitative
maternal hepatitis B surface antigen predicts maternally
transmitted hepatitis B virus infection. Hepatology. 64:1451–1461.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Niller HH, Ay E, Banati F, Demcsák A,
Takacs M and Minarovits J: Wild type HBx and truncated HBx:
Pleiotropic regulators driving sequential genetic and epigenetic
steps of hepatocarcinogenesis and progression of HBV-associated
neoplasms. Rev Med Virol. 26:57–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu L, Qi J, Zhao P, Liang X, Ju Y, Liu P,
Liu B, Guo C, Zhang L, Ma C and Gao L: T cell immunoglobulin- and
mucin-domain-containing molecule-4 attenuates concanavalin
A-induced hepatitis by regulating macrophage. J Leukoc Biol.
88:329–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qi J, Qiao Y, Wang P, Li S, Zhao W and Gao
C: MicroRNA-210 negatively regulates LPS-induced production of
proinflammatory cytokines by targeting NF-κB1 in murine
macrophages. FEBS Lett. 586:1201–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chinese Society of Infectious Diseases,
Chinese Medical Association, Chinese Society of Infectious
Diseases, Chinese Medical Association, ; Hou JL and Lai W: The
guideline of prevention and treatment for chronic hepatitis B: A
2015 update. Zhonghua Gan Zang Bing Za Zhi. (In Chinese).
23:888–905. 2015.PubMed/NCBI
|
|
15
|
Hou J, Wang G, Wang F, Cheng J, Ren H,
Zhuang H, Sun J, Li L, Li J, Meng Q, et al: Guideline of prevention
and treatment for chronic hepatitis B (2015 Update). J Clin Transl
Hepatol. 5:297–318. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang W, Bian H, Li F, Li X, Zhang D, Sun
S, Song S, Zhu Q, Ren W, Qin C and Qi J: HBeAg induces the
expression of macrophage miR-155 to accelerate liver injury via
promoting production of inflammatory cytokines. Cell Mol Life Sci.
75:2627–2641. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bian H, Li F, Wang W, Zhao Q, Gao S, Ma J,
Li X, Ren W, Qin C and Qi J: MAPK/p38 regulation of cytoskeleton
rearrangement accelerates induction of macrophage activation by
TLR4, but not TLR3. Int J Mol Med. 40:1495–1503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi J, Li T, Bian H, Li F, Ju Y, Gao S, Su
J, Ren W and Qin C: SNAI1 promotes the development of HCC through
the enhancement of proliferation and inhibition of apoptosis. FEBS
Open Bio. 6:326–337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Camps C, Buffa FM, Colella S, Moore J,
Sotiriou C, Sheldon H, Harris AL, Gleadle JM and Ragoussis J:
hsa-miR-210 is induced by hypoxia and is an independent prognostic
factor in breast cancer. Clin Cancer Res. 14:1340–1348. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang X, Ding L, Bennewith KL, Tong RT,
Welford SM, Ang KK, Story M, Le QT and Giaccia AJ:
Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Mol Cell. 35:856–867. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren CX, Leng RX, Fan YG, Pan HF, Wu CH and
Ye DQ: MicroRNA-210 and its theranostic potential. Expert Opin Ther
Targets. 20:1325–1338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang X, Le QT and Giaccia AJ:
MiR-210-micromanager of the hypoxia pathway. Trends Mol Med.
16:230–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang Y, Li L, Tan X, Liu B, Zhang Y and
Li C: miR-210 mediates vagus nerve stimulation-induced antioxidant
stress and anti-apoptosis reactions following cerebral
ischemia/reperfusion injury in rats. J Neurochem. 134:173–181.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noman MZ, Buart S, Romero P, Ketari S,
Janji B, Mari B, Mami-Chouaib F and Chouaib S: Hypoxia-inducible
miR-210 regulates the susceptibility of tumor cells to lysis by
cytotoxic T cells. Cancer Res. 72:4629–4641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Z, Li Y, Zhang H, Huang P and Luthra
R: Hypoxia-regulated microRNA-210 modulates mitochondrial function
and decreases ISCU and COX10 expression. Oncogene. 29:4362–4368.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li C, Zhao M, Zhang C, Zhang W, Zhao X,
Duan X and Xu W: miR210 modulates respiratory burst in apostichopus
japonicas coelomocytes via targeting toll-like receptor. Dev Comp
Immunol. 65:377–381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Faraonio R, Salerno P, Passaro F, Sedia C,
Iaccio A, Bellelli R, Nappi TC, Comegna M, Romano S, Salvatore G,
et al: A set of miRNAs participates in the cellular senescence
program in human diploid fibroblasts. Cell Death Differ.
19:713–721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bar I, Merhi A, Abdel-Sater F, Ben Addi A,
Sollennita S, Canon JL and Delrée P: The microRNA miR-210 is
expressed by cancer cells but also by the tumor microenvironment in
triple-negative breast cancer. J Histochem Cytochem. 65:335–346.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kushibiki T: Photodynamic therapy induces
microRNA-210 and −296 expression in HeLa cells. J Biophotonics.
3:368–372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fasanaro P, D'Alessandra Y, Di Stefano V,
Melchionna R, Romani S, Pompilio G, Capogrossi MC and Martelli F:
MicroRNA-210 modulates endothelial cell response to hypoxia and
inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol
Chem. 283:15878–15883. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu F, Yang J, Ouyang J, Zheng Y, Chen B,
Li G, Lu Z, Dong P and Zheng J: Serum microRNA-210 levels in
different groups of chronic hepatitis B patients. Clin Chim Acta.
450:203–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Zhang X, Chen L, Zhang Z, Zhang J,
Wang W, Wu M, Shi B, Zhang X, Kozlowski M, et al: Circulating
miR-210 and miR-22 combined with ALT predict the virological
response to interferon-alpha therapy of CHB patients. Sci Rep.
7:156582017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wyżewski Z, Gregorczyk KP, Szczepanowska J
and Szulc-Dąbrowska L: Functional role of Hsp60 as a positive
regulator of human viral infection progression. Acta Virol.
62:33–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hao S, Wang Y, Gao G and Li Z: Hepatitis B
virus upregulates the expression of C-reactive protein both in vivo
and in vitro. Ann Clin Lab Sci. 47:432–435. 2017.PubMed/NCBI
|
|
35
|
Vega VL, Rodríguez-Silva M, Frey T,
Gehrmann M, Diaz JC, Steinem C, Multhoff G, Arispe N and De Maio A:
Hsp70 translocates into the plasma membrane after stress and is
released into the extracellular environment in a
membrane-associated form that activates macrophages. J Immunol.
180:4299–42307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pilling D, Galvis-Carvajal E, Karhadkar
TR, Cox N and Gomer RH: Monocyte differentiation and macrophage
priming are regulated differentially by pentraxins and their
ligands. BMC Immunol. 18:302017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karayiannis P: Hepatitis B virus:
Virology, molecular biology, life cycle and intrahepatic spread.
Hepatol Int. 11:500–508. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
WHO, ; Hepatitis B: http://www.who.int/en/news-room/fact-sheets/detail/hepatitis-bJuly.
2018
|
|
39
|
Stramer SL, Wend U, Candotti D, Foster GA,
Hollinger FB, Dodd RY, Allain JP and Gerlich W: Nucleic acid
testing to detect HBV infection in blood donors. N Engl J Med.
364:236–247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Justo-Junior AS, Villarejos LM, Lima XTV,
Nadruz W Jr, Sposito AC, Mamoni RL, Abdalla R, Fernandes JL,
Oliveira RTD and Blotta MHSL: Monocytes of patients with unstable
angina express high levels of chemokine and pattern-recognition
receptors. Cytokine. 2018.
|
|
41
|
Gu X, Wei C, Zhu X, Lu F, Sheng B and Zang
X: Effect of interleukin-31 on septic shock through regulating
inflammasomes and interleukin-1β. Exp Ther Med. 16:171–177.
2018.PubMed/NCBI
|
|
42
|
Santoni G, Morelli MB, Amantini C, Santoni
M, Nabissi M, Marinelli O and Santoni A: Immuno-transient receptor
potential ion channels: The role in monocyte- and
macrophage-mediated inflammatory responses. Front Immunol.
9:12732018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schneider A, Weier M, Herderschee J,
Perreau M, Calandra T, Roger T and Giannoni E: IRF5 is a key
regulator of macrophage response to lipopolysaccharide in newborns.
Front Immunol. 9:15972018. View Article : Google Scholar : PubMed/NCBI
|
